A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.

NCT07037394 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

252

Enrollment

OTHER

Sponsor class

Conditions

Overt Hepatic Encephalopathy

Interventions

DRUG: Probiotic plus lactulose
DRUG: Rifaximin plus lactulose
DRUG: L-ornithine-L-aspartate plus latulose
DRUG: Lactulose

Sponsor

Qurratul Ain Jamil